CN104815162A - 一种治疗肺结核咯血的中药组合物 - Google Patents
一种治疗肺结核咯血的中药组合物 Download PDFInfo
- Publication number
- CN104815162A CN104815162A CN201510268561.4A CN201510268561A CN104815162A CN 104815162 A CN104815162 A CN 104815162A CN 201510268561 A CN201510268561 A CN 201510268561A CN 104815162 A CN104815162 A CN 104815162A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- medicine composition
- pulmonary tuberculosis
- hemoptysis
- traditional chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 70
- 239000000203 mixture Substances 0.000 title claims abstract description 40
- 208000008128 pulmonary tuberculosis Diseases 0.000 title claims abstract description 31
- 208000000616 Hemoptysis Diseases 0.000 title claims abstract description 29
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 37
- 229940079593 drug Drugs 0.000 claims description 17
- 238000002360 preparation method Methods 0.000 claims description 17
- 239000008187 granular material Substances 0.000 claims description 16
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 11
- 241000180649 Panax notoginseng Species 0.000 claims description 11
- UAJTZZNRJCKXJN-UHFFFAOYSA-M sodium;2-dodecoxy-2-oxoethanesulfonate Chemical compound [Na+].CCCCCCCCCCCCOC(=O)CS([O-])(=O)=O UAJTZZNRJCKXJN-UHFFFAOYSA-M 0.000 claims description 11
- 239000000706 filtrate Substances 0.000 claims description 7
- 239000006228 supernatant Substances 0.000 claims description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- 239000002775 capsule Substances 0.000 claims description 6
- 230000007812 deficiency Effects 0.000 claims description 6
- 238000007796 conventional method Methods 0.000 claims description 5
- 239000003826 tablet Substances 0.000 claims description 5
- 208000013403 hyperactivity Diseases 0.000 claims description 4
- 239000008280 blood Substances 0.000 abstract description 35
- 210000004369 blood Anatomy 0.000 abstract description 35
- 210000004072 lung Anatomy 0.000 abstract description 20
- 230000000694 effects Effects 0.000 abstract description 8
- 230000001737 promoting effect Effects 0.000 abstract description 6
- 210000000952 spleen Anatomy 0.000 abstract description 6
- 238000001816 cooling Methods 0.000 abstract description 4
- 208000001431 Psychomotor Agitation Diseases 0.000 abstract description 3
- 206010038743 Restlessness Diseases 0.000 abstract description 3
- 210000001124 body fluid Anatomy 0.000 abstract description 3
- 239000010839 body fluid Substances 0.000 abstract description 3
- 238000004519 manufacturing process Methods 0.000 abstract description 3
- 230000001502 supplementing effect Effects 0.000 abstract description 3
- 208000032843 Hemorrhage Diseases 0.000 abstract description 2
- 230000000740 bleeding effect Effects 0.000 abstract description 2
- 238000005728 strengthening Methods 0.000 abstract description 2
- 235000016993 Agrimonia Nutrition 0.000 abstract 1
- 244000307697 Agrimonia eupatoria Species 0.000 abstract 1
- 241000758794 Asarum Species 0.000 abstract 1
- 235000013717 Houttuynia Nutrition 0.000 abstract 1
- 240000000691 Houttuynia cordata Species 0.000 abstract 1
- 244000241872 Lycium chinense Species 0.000 abstract 1
- 235000015468 Lycium chinense Nutrition 0.000 abstract 1
- 241000123069 Ocyurus chrysurus Species 0.000 abstract 1
- 240000002948 Ophiopogon intermedius Species 0.000 abstract 1
- 240000002924 Platycladus orientalis Species 0.000 abstract 1
- 239000009759 San-Chi Substances 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 230000008929 regeneration Effects 0.000 abstract 1
- 238000011069 regeneration method Methods 0.000 abstract 1
- 206010011224 Cough Diseases 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 239000003172 expectorant agent Substances 0.000 description 7
- 230000003419 expectorant effect Effects 0.000 description 7
- 201000010099 disease Diseases 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 6
- 230000023597 hemostasis Effects 0.000 description 6
- 206010037660 Pyrexia Diseases 0.000 description 5
- -1 as decoction Substances 0.000 description 5
- 210000004185 liver Anatomy 0.000 description 5
- 238000010298 pulverizing process Methods 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 4
- 206010007247 Carbuncle Diseases 0.000 description 4
- 208000019802 Sexually transmitted disease Diseases 0.000 description 4
- 208000001780 epistaxis Diseases 0.000 description 4
- 230000003203 everyday effect Effects 0.000 description 4
- 235000012054 meals Nutrition 0.000 description 4
- 239000007779 soft material Substances 0.000 description 4
- 201000008827 tuberculosis Diseases 0.000 description 4
- 239000004375 Dextrin Substances 0.000 description 3
- 229920001353 Dextrin Polymers 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 235000019425 dextrin Nutrition 0.000 description 3
- 206010029410 night sweats Diseases 0.000 description 3
- 230000036565 night sweats Effects 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 201000000736 Amenorrhea Diseases 0.000 description 2
- 206010001928 Amenorrhoea Diseases 0.000 description 2
- 206010048612 Hydrothorax Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 208000033809 Suppuration Diseases 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 208000031971 Yin Deficiency Diseases 0.000 description 2
- 231100000540 amenorrhea Toxicity 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 230000001771 impaired effect Effects 0.000 description 2
- 201000003453 lung abscess Diseases 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 201000004792 malaria Diseases 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 230000017423 tissue regeneration Effects 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- MCSXGCZMEPXKIW-UHFFFAOYSA-N 3-hydroxy-4-[(4-methyl-2-nitrophenyl)diazenyl]-N-(3-nitrophenyl)naphthalene-2-carboxamide Chemical compound Cc1ccc(N=Nc2c(O)c(cc3ccccc23)C(=O)Nc2cccc(c2)[N+]([O-])=O)c(c1)[N+]([O-])=O MCSXGCZMEPXKIW-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 206010002329 Aneurysm Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 208000019838 Blood disease Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 208000006877 Insect Bites and Stings Diseases 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 241000187479 Mycobacterium tuberculosis Species 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 208000005374 Poisoning Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 231100000360 alopecia Toxicity 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000002365 anti-tubercular Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 230000004856 capillary permeability Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000009104 chemotherapy regimen Methods 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 230000002153 concerted effect Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 208000017574 dry cough Diseases 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 208000014951 hematologic disease Diseases 0.000 description 1
- 208000018706 hematopoietic system disease Diseases 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 239000001253 polyvinylpolypyrrolidone Substances 0.000 description 1
- 235000013809 polyvinylpolypyrrolidone Nutrition 0.000 description 1
- 229920000523 polyvinylpolypyrrolidone Polymers 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 238000012109 statistical procedure Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 239000009306 yunnan baiyao Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510268561.4A CN104815162B (zh) | 2015-05-23 | 2015-05-23 | 一种治疗肺结核咯血的中药组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510268561.4A CN104815162B (zh) | 2015-05-23 | 2015-05-23 | 一种治疗肺结核咯血的中药组合物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104815162A true CN104815162A (zh) | 2015-08-05 |
CN104815162B CN104815162B (zh) | 2016-06-01 |
Family
ID=53725806
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510268561.4A Expired - Fee Related CN104815162B (zh) | 2015-05-23 | 2015-05-23 | 一种治疗肺结核咯血的中药组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104815162B (zh) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101785839A (zh) * | 2010-04-23 | 2010-07-28 | 泰一和浦(北京)中医药研究院有限公司 | 一种治疗咳血的中药组合物及其制备方法 |
-
2015
- 2015-05-23 CN CN201510268561.4A patent/CN104815162B/zh not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101785839A (zh) * | 2010-04-23 | 2010-07-28 | 泰一和浦(北京)中医药研究院有限公司 | 一种治疗咳血的中药组合物及其制备方法 |
Non-Patent Citations (3)
Title |
---|
刘忠达等: "肺结核的中医药治疗进展", 《世界中医药》, no. 06, 16 November 2007 (2007-11-16) * |
樊亚巍: "中医药治疗咯血的临床研究现状", 《新中医》, no. 09, 15 September 1995 (1995-09-15) * |
王学教: "泻白止血饮为主治疗肺结核咯血68例", 《湖北中医杂志》, no. 09, 10 September 2009 (2009-09-10) * |
Also Published As
Publication number | Publication date |
---|---|
CN104815162B (zh) | 2016-06-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107050338A (zh) | 用于治疗慢性咽炎的中药组合物及制备方法 | |
CN104524337A (zh) | 一种治疗口腔溃疡的中药 | |
CN103751544B (zh) | 一种治疗褥疮的外敷膏剂 | |
CN101856481A (zh) | 一种消肿散结的外用膏剂 | |
CN102210773B (zh) | 一种治疗小儿肺炎的中药巴布膏剂和制备方法及其应用 | |
CN115282229B (zh) | 一种治疗气虚血淤型冠心病的中药组合物及其制备方法 | |
CN102671061A (zh) | 用于治疗慢性化脓性中耳炎的中药、应用及制备方法 | |
CN104771697A (zh) | 一种治疗胆囊炎的药物组合物 | |
CN104587206A (zh) | 治疗褥疮的药物及制备方法 | |
CN104383318A (zh) | 一种治疗肺结核的中药组合物及其制备方法 | |
CN103330830A (zh) | 一种治疗咽喉肿痛的药物及其制备方法 | |
CN106474386A (zh) | 一种排毒养生的组合物及其制备方法 | |
CN101829188B (zh) | 一种治疗泌尿系感染和结石病的药物 | |
CN104815162A (zh) | 一种治疗肺结核咯血的中药组合物 | |
CN104740405B (zh) | 一种治疗过敏性紫癜性肾损害的中药制剂及制备方法 | |
CN103127398B (zh) | 一种治疗癌症的中药及其制备方法 | |
CN104906472A (zh) | 一种防治咳嗽变异性哮喘病的中药组合物 | |
CN103316282A (zh) | 一种治疗溃疡性结肠炎的中药组合物及其制备方法 | |
CN107744549A (zh) | 一种治疗牙痛的药物及其制备方法 | |
CN101961453B (zh) | 治疗慢性鼻炎的中药 | |
CN105232661A (zh) | 一种治疗乳腺炎的中药组合物及其制备方法 | |
CN104587035A (zh) | 一种治疗口腔溃疡的药物组合物及其制备方法 | |
CN105998421A (zh) | 治疗子宫肌瘤的中药组合物 | |
CN105079772A (zh) | 一种治疗术后早期粘连性肠梗阻的中药组合物 | |
CN104815259A (zh) | 一种治疗肺结核的中药组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
EXSB | Decision made by sipo to initiate substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C41 | Transfer of patent application or patent right or utility model | ||
CB03 | Change of inventor or designer information |
Inventor after: Chen Haiqing Inventor after: Zhang Xuemin Inventor after: Hou Mingyue Inventor before: The inventor has waived the right to be mentioned |
|
COR | Change of bibliographic data | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20160302 Address after: 277700 Shandong Lanling County of Linyi Province Chengguan health Street No. 4 Applicant after: Chen Haiqing Address before: 1 residential building, No. 443 Changjiang East Road, Huangdao District, Shandong, China, 1708, China, 266520 Applicant before: Chen Da bio tech ltd, Qingdao |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20160601 Termination date: 20180523 |